MICHAEL J ACKERMAN, M.D.
Medical Practice at 1 St, Rochester, MN
License number
Minnesota 39291
Category
Medical Practice
Type
Pediatric Cardiology
Address
Address
200 1St St SW, Rochester, MN 55905
Phone
(507) 284-2511
Organization information
See more information about MICHAEL J ACKERMAN at bizstanding.comMayo Clinic - Michael J Ackerman MD
200 1 St SW #W4, Rochester, MN 55905
Categories:
Cardiology Physicians & Surgeons, Pediatrics Physicians & Surgeons
Phone:
(507) 284-3994 (Phone)
Professional information
Dr. Michael J Ackerman, Rochester MN - MD (Doctor of Medicine)
Specialties:
Pediatric Cardiology
Address:
Mayo Clinic
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
Certifications:
Pediatric Cardiology, 2010, Pediatrics, 1998
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Mayo Clinic
200 1St St SW, Rochester 55905
Mayo Clinic Saint Marys Hospital
1216 2Nd St South #West, Rochester 55902
200 1St St SW, Rochester 55905
Mayo Clinic Saint Marys Hospital
1216 2Nd St South #West, Rochester 55902
Education:
Medical School
Mayo Medical School
Graduated: 1995
Mayo Grad School Med/Mayo Fndn
Mayo Medical School
Graduated: 1995
Mayo Grad School Med/Mayo Fndn
Michael J Ackerman, Rochester MN
Specialties:
Pediatric Cardiologist
Address:
200 1St St Sw, Rochester, MN 55905
Education:
Doctor of Medicine
Board certifications:
American Board of Pediatrics Sub-certificate in Pediatric Cardiology (Pediatrics)
Compositions And Methods For Discovering Agents For Pharmacological Rescue Of Herg 1B Subunits For The Treatment Of Long Qt Syndrome
US Patent:
2010000, Jan 7, 2010
Filed:
Jun 24, 2009
Appl. No.:
12/490987
Inventors:
Gail A. Robertson - Madison WI, US
Michael J. Ackerman - Rochester MN, US
Pallavi Phartiyal - Washington DC, US
Michael J. Ackerman - Rochester MN, US
Pallavi Phartiyal - Washington DC, US
International Classification:
C12Q 1/68, C12N 5/06, C12N 5/08, C40B 30/04
US Classification:
435 6, 435358, 435369, 435365, 506 9
Abstract:
Cells engineered to express a detectable hERG 1b polypeptide and methods for identifying agents that facilitate hERG 1b maturation using such cells are provided. A method for analyzing a biological sample for the presence of an amino acid substitution at position 8 of the hERG 1b N-terminus is further provided.
Non-Alternating Beat-To-Beat Fluctuations In T Wave Morphology
US Patent:
6821256, Nov 23, 2004
Filed:
Feb 1, 2001
Appl. No.:
09/775176
Inventors:
Michael J. Ackerman - Rochester MN
Jan Nemec - Praha, CZ
Win-Kuang Shen - Rochester MN
Jan Nemec - Praha, CZ
Win-Kuang Shen - Rochester MN
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61B 50452
US Classification:
600508
Abstract:
The invention features methods to detect T wave lability in an individual, and methods of using T wave lability to detect or monitor abnormal cardiac activities. An individual can be assessed for the risk of sudden death due to cardiovascular pathology using methods provided by the invention. The invention also features methods of obtaining a T wave lability index for an individual. The invention further features a computer-readable storage medium for calculating an individuals T wave lability index and an apparatus for obtaining same. In addition, the invention features an article of manufacture for chemically stressing an individual for the purpose of determining a T wave lability index.
Nucleic Acid Encoding Sodium Channel Subunit
US Patent:
7485455, Feb 3, 2009
Filed:
Aug 1, 2003
Appl. No.:
10/632342
Inventors:
Jonathan C. Makielski - Fitchburg WI, US
Bin Ye - Madison WI, US
Michael J. Ackerman - Rochester MN, US
Bin Ye - Madison WI, US
Michael J. Ackerman - Rochester MN, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
Mayo Clinic Health Solutions - Rochester MN
Mayo Clinic Health Solutions - Rochester MN
International Classification:
C12N 15/12, C12N 5/10, C12N 15/63
US Classification:
4353201, 435325, 536 231, 536 235, 536 241
Abstract:
The present invention discloses four groups of SCN5A variants that represent the most common SCN5A variants in humans. A specific mutation in one of the variants has been shown to display a different phenotype in relation to a human heart disease than other variants and known human sodium channel α subunits with corresponding mutations. The present invention provides new tools to study mutations and to design or identify new diagnostic and treatment strategies or agents for sodium channel related diseases or conditions.
Identifying Susceptibility To Cardiac Hypertrophy
US Patent:
7572586, Aug 11, 2009
Filed:
Nov 1, 2006
Appl. No.:
11/555548
Inventors:
Michael J. Ackerman - Rochester MN, US
Sara Van Driest - Nashville TN, US
Sara Van Driest - Nashville TN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C12Q 1/68, C12P 19/34
US Classification:
435 6, 435 912, 536 243
Abstract:
This document provides methods and materials related to identifying, assessing, and predicting hypertrophic cardiomyopathy (HCM) in mammals. For example, methods and materials for using mutations (e. g. , mutations in ZASP and MYBPC3 nucleic acids) to identify, assess, and predict HCM in mammals (e. g. , humans) are provided.
Method Of Genetic Testing In Heritable Arrhythmia Syndrome Patients
US Patent:
2005014, Jun 30, 2005
Filed:
Oct 27, 2004
Appl. No.:
10/976086
Inventors:
Michael Ackerman - Rochester MN, US
International Classification:
C12Q001/68, G06F019/00, G01N033/48, G01N033/50
US Classification:
435006000, 702020000
Abstract:
A method of diagnosing heritable arrhythmia syndrome in a patient is disclosed. In one embodiment, the method comprises the steps of (a) isolating a nucleic acid sample from the patient and (b) comparing the nucleic acid sample to the compendium of novel DNA mutations disclosed in Table 1, wherein the comparison is to the mutations described from at least one of the genes selected from the group consisting of KCNQ1, KCNH2, SCN5A, and KCNE2.
Ryr2 Mutations
US Patent:
2008028, Nov 20, 2008
Filed:
Apr 27, 2007
Appl. No.:
11/741628
Inventors:
Michael J. Ackerman - Rochester MN, US
David J. Tester - Rochester MN, US
Melissa L. Will - Dodge Center MN, US
Carla M. Haglund - Pine Island MN, US
David J. Tester - Rochester MN, US
Melissa L. Will - Dodge Center MN, US
Carla M. Haglund - Pine Island MN, US
International Classification:
G01N 33/00
US Classification:
436 86, 436 94
Abstract:
This document provides methods and materials related to assessing a mammal for the presence or absence of a genetic mutation. For example, methods for determining whether or not a mammal contains a genetic mutation in an RyR2 sequence are provided. In addition, isolated nucleic acid molecules containing an RyR2 sequence and encoding a mutation are provided herein.